Metronidazole validates drugs targeting hypoxic bacteria for improved treatment of tuberculosis.
Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA. yzhang@jhsph.edu
Ying
Y
Zhang
D000818:Animals; D055985:Latent Tuberculosis / Q000188:drug therapy*; D008795:Metronidazole / Q000494:pharmacology*; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D008795:Metronidazole